Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da049e92a8a157f91636283e11f56b5d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2017-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94e1794b39a9f09e2dcc33b554018703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8add64b90811142744e296c4c884fcfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22c158d6b3d1b4690cdbcad5b9940f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b990b21c2afcf30912797d25c3fef1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96da3fa116eef314c72e8e0705757750 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a49049183a66bfed27fc2b89c8507c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b217195c90106f1106665ec26b2422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a46291e3062b8483e0b0a318c2190a6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80bd6dd9bb238b490b49a4847170ee4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f72316878dc19e30b2d6098760e3f2 |
publicationDate |
2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11447565-B2 |
titleOfInvention |
Method for treating a GD2 positive cancer |
abstract |
The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day. |
priorityDate |
2012-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |